Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00411450
What this trial is testing

Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+4 more
Amgen 116
Not applicableStudy completedNCT01596790
What this trial is testing

COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University Hospital, Montpellier 168
Testing effectiveness (Phase 2)UnknownNCT02624726
What this trial is testing

Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment

Who this might be right for
Metastatic Colorectal Cancer
Hellenic Oncology Research Group 31
Early research (Phase 1)Study completedNCT00780169
What this trial is testing

Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Ottawa Hospital Research Institute 16
Testing effectiveness (Phase 2)Study completedNCT00422773
What this trial is testing

Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Technische Universität Dresden 21
Testing effectiveness (Phase 2)Looking for participantsNCT06922383
What this trial is testing

A Clinical Study of Arfolitixorin in Patients With mCRC

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Isofol Medical AB 90
Early research (Phase 1)Looking for participantsNCT07543744
What this trial is testing

A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI

Who this might be right for
Metastatic Colorectal Cancer
R-Pharm 180
Testing effectiveness (Phase 2)Study completedNCT00217711
What this trial is testing

Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute 23
Not applicableStudy completedNCT01483027
What this trial is testing

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Boston Scientific Corporation 428
Testing effectiveness (Phase 2)WithdrawnNCT01889680
What this trial is testing

Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Colorectal Cancer
NSABP Foundation Inc
Testing effectiveness (Phase 2)Study completedNCT01674309
What this trial is testing

First Line Treatment by FOLFIRINOX for Patients With a Rectum Cancer With Synchronous Non Resectable Metastasis

Who this might be right for
Adenocarcinoma of Rectum
Federation Francophone de Cancerologie Digestive 65
Testing effectiveness (Phase 2)Study completedNCT01163396
What this trial is testing

First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Gruppo Oncologico del Nord-Ovest 57
Testing effectiveness (Phase 2)Study completedNCT00345696
What this trial is testing

1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.

Who this might be right for
Metastatic Colorectal Cancer
Unidad Integral de Investigación en Oncología S.L. 32
Testing effectiveness (Phase 2)Study completedNCT02291289
What this trial is testing

Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 1,044
Not applicableLooking for participantsNCT06808685
What this trial is testing

Real World Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab Elovie

Who this might be right for
Metastatic Colorectal Cancer
Libbs Farmacêutica LTDA 133
Testing effectiveness (Phase 2)Study completedNCT02404935
What this trial is testing

Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients wtRAS mCRC)

Who this might be right for
Metastatic Colorectal Cancer
UNICANCER 139
Large-scale testing (Phase 3)Study completedNCT00469443
What this trial is testing

Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC

Who this might be right for
Colorectal Cancer
Hellenic Oncology Research Group 330
Not applicableStudy completedNCT01822444
What this trial is testing

ANGIOPREDICT. ICORG 12-16, V3

Who this might be right for
Advanced Colorectal Cancer
Cancer Trials Ireland 76
Early research (Phase 1)Study completedNCT01124630
What this trial is testing

Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments

Who this might be right for
Metastatic Colorectal Cancer
Daiichi Sankyo 21
Testing effectiveness (Phase 2)Study completedNCT00286130
What this trial is testing

Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Central European Cooperative Oncology Group 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation